other material
confidence high
sentiment neutral
materiality 0.55
BioVie raises $4.74M in registered direct at $1.60/share; issues 2.96M common warrants at $1.70
BIOVIE INC.
- Sold 960,000 shares at $1.60 and 2,002,500 pre-funded warrants at $1.5999 (exercise price $0.0001) to a single healthcare-focused institutional investor.
- Concurrent private placement of 2,962,500 common warrants at $1.70 exercise price, exercisable six months after issuance and expiring 5.5 years from issuance.
- Aggregate gross proceeds ~$4.74M before fees; A.G.P./Alliance Global Partners was sole placement agent with a 7.0% cash fee; net proceeds for working capital and general corporate purposes.
- Company agreed to a 60-day standstill on new equity issuance, a six-month ban on variable-rate transactions, and directors/officers locked up 60 days post-close.
- Offering closed November 5, 2026; shares sold under the Form S-3 shelf (File No. 333-296924); BioVie must file a resale registration for the common warrant shares.